Sustainability, affordability, and equity of corporate drug donations: the case of Malarone

Lancet. 2000 May 13;355(9216):1718-20. doi: 10.1016/s0140-6736(00)02251-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / economics*
  • Atovaquone
  • Charities / economics*
  • Developing Countries*
  • Drug Combinations
  • Drug Industry / economics*
  • Humans
  • Kenya
  • Naphthoquinones / economics*
  • Proguanil / economics*

Substances

  • Antimalarials
  • Drug Combinations
  • Naphthoquinones
  • atovaquone, proguanil drug combination
  • Proguanil
  • Atovaquone